Idelalisib (CAL-101) | PI3Kδ Inhibitor

Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}			Login	- +	Inquiry

NCT03310190	-		Recruiting	June 15, 2020	Canada, Alberta ... More >> University of Calgary /ID# 166416 Recruiting Calgary, Alberta, Canada, T2N 4Z6 Cross Cancer Institute /ID# 166417 Not yet recruiting Edmonton, Alberta, Canada, T6G 1Z2 Canada, New Brunswick The Moncton Hospital /ID# 166043 Recruiting Moncton, New Brunswick, Canada, E1C 6Z8 Saint John Regional Hospital /ID# 202190 Not yet recruiting Saint John, New Brunswick, Canada, E2L 4L2 Canada, Ontario William Osler Health System /ID# 202049 Not yet recruiting Brampton, Ontario, Canada, L6R 3J7 Michael Garron Hospital/Toronto East Health Network /ID# 209463 Not yet recruiting East York, Ontario, Canada, M4C 3E7 Kingston Health Sciences Centr /ID# 169252 Recruiting Kingston, Ontario, Canada, K7L 2V7 The Ottawa Hospital Research /ID# 166041 Recruiting Ottawa, Ontario, Canada, K1H 8L6 Health Sciences North /ID# 205817 Recruiting Sudbury, Ontario, Canada, P3N 1H5 Canada, Quebec Jewish General Hospital /ID# 166418 Recruiting Montreal, Quebec, Canada, H3T 1E2 Cisss Du Bas-Saint-Laurent Hopital Regional de Rimouski /Id# 201202 Recruiting Rimouski, Quebec, Canada, G5L 5T1 Canada CancerCare Manitoba /ID# 170751 Recruiting Manitoba, Canada, R3E 0V9 Thunder Bay Regional Health Re /ID# 204740 Not yet recruiting Thunder Bay, Canada, P7B 6V4 Less <<
NCT03283137	CLL B-cell No... More >>n Hodgkin Lymphoma Less <<	Phase 1	Recruiting	December 2020	United States, Illinois ... More >> University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Michael Thirman, MD mthirman@medicine.bsd.uchicago.edu Contact: Howard Weiner 7737022084 hweiner@medicine.bsd.uchicago.edu Less <<
NCT02141282	Chronic Lymphocytic Leukemia	Phase 2	Active, not recruiting	December 8, 2021	United States, California ... More >> Ucsd /Id# 128535 La Jolla, California, United States, 92037 University of California, Los Angeles /ID# 127262 Los Angeles, California, United States, 90095 Stanford Univ School of Med /ID# 126495 Stanford, California, United States, 94305-2200 United States, District of Columbia Medstar Georgetown Univ Med Ct /ID# 127261 Washington, District of Columbia, United States, 20007 United States, Georgia Emory University Hospital /ID# 131249 Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University /ID# 126497 Chicago, Illinois, United States, 60611-2927 United States, Massachusetts Beth Israel Deaconess Med Ctr /ID# 134509 Boston, Massachusetts, United States, 02215-5400 Dana-Farber Cancer Institute /ID# 126496 Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic - Rochester /ID# 130013 Rochester, Minnesota, United States, 55905-0001 United States, New York Columbia Univ Medical Center /ID# 128536 New York, New York, United States, 10032-3725 New York Presbyterian Hospital - Weill Cornell Medical Center /ID# 129648 New York, New York, United States, 10032-3725 Univ Rochester Med Ctr /ID# 130011 Rochester, New York, United States, 14642 United States, Ohio The Ohio State University - Columbus /ID# 127263 Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pennsylvania /ID# 126860 Philadelphia, Pennsylvania, United States, 19104-5502 United States, Texas Univ TX, MD Anderson /ID# 126498 Houston, Texas, United States, 77030 United States, Utah University of Utah /ID# 129984 Salt Lake City, Utah, United States, 84112-5500 University of Utah /ID# 130813 Salt Lake City, Utah, United States, 84112-5500 Less <<
NCT02742090	Chronic Lymphocytic Leukemia	Phase 2	Active, not recruiting	December 2019	United States, District of Col... More >>umbia TG Therapeutics Investigational Trial Site Washington, District of Columbia, United States, 20007 United States, Florida TG Therapeutics Investigational Trial Site Fort Myers, Florida, United States, 33916 TG Therapeutics Investigational Trial Site Saint Petersburg, Florida, United States, 33705 United States, Missouri TG Therapeutics Investigational Trial Site Kansas City, Missouri, United States, 64132 United States, New Hampshire TG Therapeutics Investigational Trial Site Lebanon, New Hampshire, United States, 03756 United States, New Jersey TG Therapeutics Investigational Trial Site Hackensack, New Jersey, United States, 07601 United States, New York TG Therapeutics Investigational Trial Site New Hyde Park, New York, United States, 11042 TG Therapeutics Investigational Trial Site New York, New York, United States, 10032 TG Therapeutics Investigational Trial Site Rochester, New York, United States, 14642 United States, North Carolina TG Therapeutics Investigational Trial Site Durham, North Carolina, United States, 27710 United States, Pennsylvania TG Therapeutics Investigational Trial Site Hershey, Pennsylvania, United States, 17033 TG Therapeutics Investigational Trial Site Philadelphia, Pennsylvania, United States, 19146 United States, Tennessee TG Therapeutics Investigational Trial Site Nashville, Tennessee, United States, 37203 United States, Washington TG Therapeutics Investigational Trial Site Seattle, Washington, United States, 98104 Less <<
NCT01644253	Chronic Lymphocytic Leukemia ... More >> Peripheral T-cell Lymphoma Less <<	Phase 1	Active, not recruiting	December 2019	United States, Georgia ... More >> Augusta, Georgia, United States, 30912 United States, Ohio Columbus, Ohio, United States, 43210 United States, South Carolina Greenville Health System Greenville, South Carolina, United States, 29605 United States, Texas Houston, Texas, United States, 77030 United States, Washington Swedish Cancer Institute,1221 Madison St. Seattle, Washington, United States, 98104 Less <<
NCT02457598	B-cell Malignancies	Phase 1	Active, not recruiting	May 2022	United States, District of Col... More >>umbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Indiana Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States, 46506 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 France CHRU de Lille, Hopital Claude Huriez Lille, France, 59037 Hopital Saint Eloi Montpellier, France, 34295 Chu Haut Leveque Pessac, France, 33604 Centre Hospitalier de Lyon Sud Pierre Benite, France, 69310 Institut Universitaire du Cancer-Oncopole I.U.C.T-O Toulouse, France United Kingdom Cambridge University Hospitals NHS Foundation Trust - Addenbrooke's Hospital Cambridge, England, United Kingdom Leeds Teaching Hosptials NHS Trust, Dept of Haematology Leeds, England, United Kingdom, LS9 7TF University Hospital Southampton NHS Foundation Trust Southampton, England, United Kingdom, SO16 6YD Cardiff and Vale Health Board, Clinical Research Facility Cardiff, United Kingdom, CF14 4XW University Hospitals of Leicester NHS Trust Leicester, United Kingdom, LE1 5WW The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Plymouth Hospitals NHS Trust Plymouth, United Kingdom, PL6 8BG Less <<
NCT03757000	B-cell Lymphoma Recurrent ... More >> B-cell Chronic Lymphocytic Leukemia Less <<	Phase 1	Recruiting	May 30, 2019	China, Beijing ... More >> Peking Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Yuqin Song, MD,PhD 86 10-88140650 songyuqin622@163.com Contact: Meifeng Tu, MD,PhD 86 10-88121122 44329472@qq.com Principal Investigator: Yuqin Song, MD,PhD Sub-Investigator: Meifeng Tu, MD,PhD Sub-Investigator: Lingyan Ping, MD,PhD China, Jiangsu Jiangsu Province Hospital Not yet recruiting Nanjing, Jiangsu, China, 210029 Contact: Jiangyong Li, MD,PhD 86 25-83714511 lijianyonglm@126.com Contact: Wei Xu, MD,PhD 86 25-83714511 xuwei0484@jsph.org.cn Principal Investigator: Jianyong Li, MD,PhD Sub-Investigator: Meifeng Tu, MD,PhD China, Tianjin Hematology Hospital of Chinese Academy of Medical Sciences Recruiting Tianjin, Tianjin, China, 300020 Contact: Lugui Qiu, MD,PhD 86 22-23909172 qiulg@ihcams.ac.cn Contact: Junyuan Qi, MD,PhD 86 22-23909999 qijy@ihcams.ac.cn Principal Investigator: Lugui Qiu, MD,PhD Sub-Investigator: Junyuan Qi, MD,PhD Less <<
NCT02993536	-		Unknown	-	United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Anthony Mato, MD 855-216-0098 PennCancerTrials@emergingmed.com Principal Investigator: Anthony Mato, MD Less <<
NCT02332980	Recurrent Chronic Lymphocytic ... More >>Leukemia Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Nodal Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Recurrent Splenic Marginal Zone Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Refractory Follicular Lymphoma Refractory Lymphoplasmacytic Lymphoma Refractory Nodal Marginal Zone Lymphoma Refractory Small Lymphocytic Lymphoma Refractory Splenic Marginal Zone Lymphoma Richter Syndrome Waldenstrom Macroglobulinemia Less <<	Phase 2	Recruiting	January 5, 2020	United States, Arizona ... More >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Clinical Trials Referral Office 855-776-0015 Principal Investigator: Jose F. Leis United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office 855-776-0015 Principal Investigator: Wei Ding Less <<
NCT02779283	Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Less <<	Phase 1	Recruiting	June 1, 2019	United States, Oregon ... More >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Stephen E. Spurgeon 503-494-8950 spurgeos@ohsu.edu Principal Investigator: Stephen E. Spurgeon Less <<
NCT02824159	-		Recruiting	November 2020	France ... More >> Cancer University Institute of Toulouse Oncopole Recruiting Toulouse, France, 31059 Contact: Guy Laurent, MD 5 31 15 62 09 ext +33 Laurent.guy@iuct-oncopole.fr Contact: Sandra Debaros 5.61.14.59.89 ext +33 debarros.s@chu-toulouse.fr Less <<
NCT02970318	Chronic Lymphocytic Leukemia	Phase 3	Recruiting	March 2020	United States, California ... More >> Ventura County Hematology-Oncology Specialists Recruiting Oxnard, California, United States, 93030 United States, Illinois Joliet Oncology Hematology Associates, Ltd Recruiting Joliet, Illinois, United States, 60435 United States, Iowa Physicians Clinic of Iowa, P.C. Recruiting Cedar Rapids, Iowa, United States, 52403 United States, Kentucky Montgomery Cancer Center Recruiting Mount Sterling, Kentucky, United States, 40353 United States, Minnesota Coborn Cancer Center Recruiting Saint Cloud, Minnesota, United States, 56303 United States, Nebraska Nebraska Hematology-Oncology Recruiting Lincoln, Nebraska, United States, 68506 United States, New Jersey New Jersey Hematology / Oncology Associates Recruiting Bricktown, New Jersey, United States, 08724 United States, New York Hematology Oncology Associates of Rockland Recruiting Nyack, New York, United States, 10960 United States, Ohio Gabrail Cancer Center Recruiting Canton, Ohio, United States, 44718 United States, Texas Brooke Army Medical Center Recruiting Fort Sam Houston, Texas, United States, 78234 Baylor Scott & White Health Recruiting Round Rock, Texas, United States, 78665 Less <<
NCT02787369	Recurrent Chronic Lymphoid Leu... More >>kemia Less <<	Phase 1	Active, not recruiting	April 2022	United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02603445	Follicular Lymphoma, Mantle Ce... More >>ll Lymphoma Less <<	Phase 1	Completed	-	United States, New York ... More >> Novartis Investigative Site New York, New York, United States, 10017 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030 Austria Novartis Investigative Site Salzburg, Austria, 5020 France Novartis Investigative Site Pierre-Benite Cedex, France, 69495 Novartis Investigative Site Toulouse Cedex 9, France, 31059 Germany Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Mainz, Germany, 55131 Less <<
NCT03701438	-		Enrolling by invitation	March 2020	France ... More >> Centre Hospitalier Le Mans Le Mans, France, 72037 Centre Hospitalier Regional et Univeritaire de Tours Tours, France, 37044 Spain Hospital del Mar (Servei d'Hematologia Clinica) Barcelona, Spain, 08003 Hospital Universitario Ramon y Cajal Madrid, Spain, 28034 Hospital Son Llatzer Palma de Mallorca, Spain, 07198 Less <<
NCT03469895	-		Active, not recruiting	July 2018	France ... More >> Institut Paoli Calmettes Marseille, Bouches Du Rhone, France, 13009 Less <<
NCT01732926	Indolent Non-Hodgkin's Lymphom... More >>as Less <<	Phase 3	Terminated	-	-
NCT01088048	Indolent Non-Hodgkin's Lymphom... More >>a Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Less <<	Phase 1	Completed	-	United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, California UCLA Los Angeles, California, United States, 90024 Stanford Cancer Center Palo Alto, California, United States, 94304-5548 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 Weill Medical College of Cornell New York, New York, United States, 10021 United States, Oregon Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States, 97477 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Houston, Texas, United States, 77030 United States, Washington North Star Lodge Cancer Center Yakima, Washington, United States, 98902 Less <<
NCT01644799	Recurrent Follicular Lymphoma	Phase 1	Completed	-	United States, District of Col... More >>umbia MedStar Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Weill Medical College of Cornell University New York, New York, United States, 10065 United States, North Carolina University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT02136511	-		-	-	United States, California ... More >> University of California, San Diego - Moores Cancer Center La Jolla, California, United States, 92093-0820 United States, District of Columbia Georgetown University Washington, District of Columbia, United States, 20007 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Weill Cornell Medical College New York, New York, United States, 10021 Ireland St. James University Hospital Dublin, Ireland, 8 Italy Ospedale San Raffaele Milano, Italy, 20132 A.S.O. Molinette S. Giovanni Battista Turin, Italy, 10126 United Kingdom Hammersmith Hospital London, United Kingdom, W12 0HS Less <<
NCT02639910	Leukemia, Lymphocytic, Chronic... More >>, B-Cell Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Less <<	Phase 2	Active, not recruiting	-	United States, Florida ... More >> Clinical Study Site Jacksonville, Florida, United States, 32204 United States, Minnesota Clinical Study Site Rochester, Minnesota, United States, 55905 United States, Ohio Clinical Study Site Columbus, Ohio, United States, 43210 Austria Clinical Study Site Graz, Austria, 8036 Clinical Study Site Salzburg, Austria, 5020 Clinical Study Site Wien, Austria, 1090 Germany Clinical Study Site Dresden, Germany, 1307 Clinical Study Site Leipzig, Germany, 4103 Clinical Study Site Muenchen, Germany, 80804 Italy Clinical Study Site Brescia, Italy, 25123 Clinical Study Site Milano, Italy, 20162 Poland Clinical Study Site Gdansk, Poland, 80952 Clinical Study Site Krakow, Poland, 30510 Clinical Study Site Lublin, Poland, 85094 Clinical Study Site Opole, Poland, 45372 United Kingdom Clinical Study Site Bournemouth, United Kingdom, BH7 7DW Clinical Study Site Leeds, United Kingdom, LS9 7TF Less <<
NCT01838434	Relapsed/Refractory Mantle Cel... More >>l Lymphoma Less <<	Phase 1	Completed	-	United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT03349346	Diffuse Large B-Cell Lymphoma ... More >> Mediastinal B-cell Lymphoma Less <<	Phase 1	Withdrawn(The European Medical... More >> Agency granted a Paediatric Investigational Product-specific waiver on the grounds that idelalisib is likely to be unsafe in paediatrics) Less <<	February 2026	France ... More >> Centre Hospitalier Régional Universitaire de Lille Lille, France, 59000 Italy Istituto Giannina Gaslini Genova, Italy, 16147 Ospedale Pediatrico Bambino Gesu Roma, Italy, 00165 Infantile Regina Margherita Hospital Torino, Italy, 10126 Poland Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu Wrocław, Poland, 50-556 Spain Hospital Vall d´Hebrón Barcelona, Spain, 08035 Hospital Universitario HM Monteprincipe Madrid, Spain, 28660 Less <<
NCT01569295	Chronic Lymphocytic Leukemia	Phase 3	Active, not recruiting	November 2018	-
NCT02968563	Chronic Lymphocytic Leukemia	Phase 2	Recruiting	February 2024	Germany ... More >> Recruiting Mutlangen, Baden-Wuerttemberg, Germany Recruiting Ravensburg, Baden-Wuerttemberg, Germany Recruiting Tübingen, Baden-Württemberg, Germany Recruiting Ulm, Baden-Württemberg, Germany Recruiting Augsburg, Bavaria, Germany Recruiting München, Bavaria, Germany Recruiting Erlangen, Bayern, Germany Recruiting München, Bayern, Germany Recruiting Regensburg, Bayern, Germany Withdrawn Wurzburg, Bayern, Germany Recruiting Frankfurt, Brandenburg, Germany Recruiting Gießen, Hessen, Germany Recruiting Koln, Nordrhein-Westfalen, Germany Recruiting Mönchengladbach, Nordrhein-Westfalen, Germany Recruiting Paderborn, Nordrhein-Westfalen, Germany Recruiting Neunkirchen, Saarland, Germany Recruiting Leipzig, Sachsen, Germany Recruiting Kiel, Schleswig-Holstein, Germany Recruiting Luebeck, Germany Recruiting Mannheim, Germany Withdrawn Muenchen, Germany Less <<
NCT01980888	Chronic Lymphocytic Leukemia	Phase 3	Terminated	-	-
NCT03576443	Diffuse Large B Cell Lymphoma	PHASE2	COMPLETED	2021-09-30	Aarhus University Hospital, Aa... More >>rhus C, 8000, Denmark\|Odense University Hospital, Odense, Denmark\|Halmstad County Hospital, Halmstad, 30 233, Sweden\|Linkoping University Hospital, Link?ping, 581 85, Sweden\|Skane University Hospital, Lund, 221 85, Sweden\|Karolinska University Hospital, Stockholm, 141 86, Sweden Less <<
NCT01980888	-		Terminated	-	-
NCT03545035	-		Not yet recruiting	December 2019	-
NCT01980875	-		Terminated	-	-
NCT01732913	Indolent Non-Hodgkin's Lymphom... More >>as Less <<	Phase 3	Terminated	-	-
NCT02962401	Waldenstrom Macroglobulinemia	Phase 2	Active, not recruiting	March 2025	France ... More >> Project manager Tours, France, 37044 Less <<
NCT01569295	-		Active, not recruiting	-	-
NCT01732913	-		Terminated	-	-
NCT02928510	Absence of Signs or Symptoms ... More >> B-Cell Non-Hodgkin Lymphoma Digestive System Signs and Symptoms Indolent Adult Non-Hodgkin Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Indolent Adult Non-Hodgkin Lymphoma Recurrent Small Lymphocytic Lymphoma Less <<	Not Applicable	Recruiting	February 1, 2029	United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Daniel Hommes 310-206-5403 dhommes@mednet.ucla.edu Principal Investigator: Daniel Hommes Less <<
NCT02538614	Chronic Lymphocytic Leukemia (... More >>CLL) Less <<	Phase 1	Terminated	-	United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States United States, Utah University of Utah Salt Lake City, Utah, United States Less <<
NCT01980875	Chronic Lymphocytic Leukemia	Phase 3	Terminated	-	United States, California ... More >> Sansum Clinic Santa Barbara, California, United States, 93105 UCLA Jonsson Comprehensive Cancer Center Santa Monica, California, United States, 90404 Innovative Clinical Research Institute Whittier, California, United States, 90603 United States, Connecticut Cancer Center of Central Connecticut Southington, Connecticut, United States, 06489 United States, Ohio Gabrail Cancer Center Research Canton, Ohio, United States, 44718 United States, South Carolina Saint Francis Cancer Center Greenville, South Carolina, United States, 29607 Australia, New South Wales St Vincent Hospital, Sydney Darlinghurst, New South Wales, Australia, 2010 Belgium UZ Ghent- hematology Ghent, Belgium, 9000 Canada, Ontario Royal Victoria Regional Health Centre - Simcoe Musk Barrie, Ontario, Canada, L4M 6M2 France Centre Hospitalier du Mans Le Mans, France, 72037 Centre Hospitalier de Perpignan Perpignan Cedex 9, France, 66046-BP 49954 Poland Szpital Specjalistyczny w Brzozowie, Oddzial Hematologii Onkologicznej Brzozow, Podkarpackie, Poland, 36-200 Malopolskie Centrum Medyczne s.c. Krakow, Poland, 30-510 Wojewódzki Szpital Specjalistyczny w Legnicy Legnica, Poland, 59-220 Wojewodzki Szpital Specjalistyczny, im. M. Kopernika Klinika Hematologii Uniwersytetu Medycznego Lodz, Poland, 93-510 Samodzielny Publiczny Zaklad Opieki Zdrowotnej Ministerstwa Spraw Wewnetrznych z Warminsko-Mazurskim Centrum Onkologii w Olsztynie Oddzial Hematologii Olsztyn, Poland, 10-228 Spain Hospital Universitario de Salamanca Salamanca, Spain, 37007 United Kingdom East Kent Hospitals University NHS Foundation Trust Canterbury, Kent, United Kingdom, CT1 3NG Less <<
NCT02044822	-		Terminated	-	-
NCT01732926	-		Terminated	-	-
NCT02662296	Prolymphocytic Leukemia ... More >> Recurrent Chronic Lymphocytic Leukemia Recurrent Non-Hodgkin Lymphoma Recurrent Small Lymphocytic Lymphoma Less <<	Phase 2	Withdrawn(Low enrollment)	-	United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01539512	-		Completed	-	-
NCT02258529	-		Terminated	-	-
NCT01539512	Chronic Lymphocytic Leukemia	Phase 3	Completed	-	-
NCT02044822	B-cell Chronic Lymphocytic Leu... More >>kemia (CLL) With 17p Deletion Less <<	Phase 2	Terminated	-	-
NCT03257722	Non Small Cell Lung Cancer ... More >> Metastasis Recurrence Less <<	Phase 1 Phase 2	Recruiting	August 2021	United States, Georgia ... More >> Georgia Cancer Center at Augusta University Recruiting Augusta, Georgia, United States, 30912 Less <<
NCT02258529	Follicular Lymphoma ... More >> Small Lymphocytic Lymphoma Less <<	Phase 2	Terminated	-	United States, California ... More >> Pacific Shores Medical Group Long Beach, California, United States, 90813 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33916 United States, Maryland St. Agnes Hospital Baltimore, Maryland, United States, 21229 United States, South Dakota Prarie Lakes Health Care Systems, Inc. Watertown, South Dakota, United States, 57201 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37203 United States, Washington Northwest Medical Specialties, PLLC Tacoma, Washington, United States, 98405 Less <<
NCT01203930	Chronic Lymphocytic Leukemia (... More >>CLL) Small Lymphocytic Lymphoma (SLL) Less <<	Phase 2	Terminated	-	United States, California ... More >> University of California, San Diego, Moores Cancer Center La Jolla, California, United States, 92093-0820 Stanford University School of Medicine Stanford, California, United States, 94304 United States, New York Columbia University - Herbert Irving Pavilion New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas The Universtity of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01796470	Chronic Lymphocytic Leukemia ... More >> Mantle Cell Lymphoma Diffuse Large B-cell Lymphoma Indolent Non-Hodgkin's Lymphoma Less <<	Phase 2	Completed	-	United States, California ... More >> Marin Cancer Care Greenbrae, California, United States, 94904 UC San Diego Moores Cancer Center La Jolla, California, United States, 92093 Pacific Shores Medical Group Long Beach, California, United States, 90813 Ventura County Hematology Oncology Specialists Oxnard, California, United States, 93030 Cancer Center of Santa Barbara Santa Barbara, California, United States, 93105 United States, District of Columbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Florida Collaborative Research Group LLC Boynton Beach, Florida, United States, 33435 United States, Kentucky Montgomery Cancer Center Mount Sterling, Kentucky, United States, 40353 United States, New York New York University School of Medicine New York, New York, United States, 10016 Weill Cornell Medical College New York, New York, United States, 10021 University of Rochester, James P. Wilmot Cancer Center Rochester, New York, United States, 14642 United States, Ohio Signal Point Clinical Research Center, LLC Middletown, Ohio, United States, 45042 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, South Carolina Charleston Hematology Oncology Charleston, South Carolina, United States, 29414 Hollings Cancer Center Charleston, South Carolina, United States, 29425 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Utah Cancer Specialists Salt Lake City, Utah, United States, 84106 United States, Washington Northwest Medical Specialties Tacoma, Washington, United States, 98405 Less <<
NCT01539291	Chronic Lymphocytic Leukemia	PHASE3	TERMINATED	2018-06-29	Clearview Cancer Institute, Hu... More >>ntsville, Alabama, 35805, United States\|Arizona Oncology Associates, Tucson, Arizona, 85704, United States\|University of California, San Diego - Moores Cancer Center, La Jolla, California, 92093, United States\|Ventura County Hematology Oncology Specialists, Oxnard, California, 93030, United States\|UCLA, Santa Monica, California, 90404, United States\|Stanford Cancer Center, Stanford, California, 94305, United States\|Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado, 80218, United States\|Rocky Mountain Cancer Center, Denver, Colorado, 80218, United States\|Georgetown University Medical Center Lombardi Cancer Center, Washington, District of Columbia, 20007, United States\|Collaborative Research Group, Boynton Beach, Florida, 33435, United States\|Florida Cancer Specialists, Fort Myers, Florida, 33916, United States\|Florida Cancer Specialists, Saint Petersburg, Florida, 33705, United States\|Northwestern University, Chicago, Illinois, 60611, United States\|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States\|Long Island Jewish Medical Center, New Hyde Park, New York, 11042, United States\|Weill Cornell Medical College, New York, New York, 10021, United States\|Columbia University Medical Center, New York, New York, 10032, United States\|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States\|Willamette Valley Cancer Center, Springfield, Oregon, 97477, United States\|Northwest Cancer Specialists, PC, Tualatin, Oregon, 97062, United States\|Cancer Centers of the Carolinas, Greenville, South Carolina, 29605, United States\|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States\|Texas Oncology, P.A., Fort Worth, Texas, 76104, United States\|M.D. Anderson Cancer Center, Houston, Texas, 77030, United States\|Cancer Care Network of South Texas, San Antonio, Texas, 78217, United States\|Virginia Cancer Specialists, PC, Fairfax, Virginia, 22031, United States\|Oncology and Hematology Associates of Southwest Virginia, Inc., Roanoke, Virginia, 24014, United States\|Seattle Cancer Care Alliance, Seattle, Washington, 98109-1024, United States\|Yakima Valley Memorial Hospital/North Star Lodge, Yakima, Washington, 98902, United States\|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States\|Centre Hospitalier Lyon Sud, Pierre Benite, 69495, France\|Centre Henri Becquerel, Rouen, 76038, France\|H?matologische und Internistische Gemeinschaftspraxis Dres. Eckart / H?cker, Erlangen, 91052, Germany\|Universit?tsklinikum K?ln, K?ln, 50937, Germany\|Ospedale San Raffaele S.r.l., Milano, 20132, Italy\|Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, 10126, Italy\|Royal Bournemouth Hospital, Bournemouth, BH7 7DW, United Kingdom\|Addenbrooke's Hospital, Cambridge, CB2 0QQ, United Kingdom\|Dorset County Hospital, Dorchester, DT1 2JY, United Kingdom\|Northwick Park Hospital, Harrow, HA1 3UJ, United Kingdom\|St James's University Hospital, Leeds, LS9 7TF, United Kingdom\|Royal Liverpool University Hospital, Liverpool, L7 8XP, United Kingdom\|Hammersmith Hospital, London, W12 0NN, United Kingdom\|Princess Royal University Hospital, Orpington, BR6 8ND, United Kingdom\|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom Less <<
NCT02468557	Pancreatic Ductal Adenocarcino... More >>ma Less <<	Phase 1	Terminated	-	United States, Arizona ... More >> Scottsdale Healthcare Clinical Research Institute Scottsdale, Arizona, United States, 85258 United States, California Cedars Sinai Medical Center Los Angeles, California, United States, 90048 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, District of Columbia Georgetown University Washington, District of Columbia, United States, 20007 United States, Indiana Indiana University Goshen Center for Cancer Care Goshen, Indiana, United States, 46506 United States, Massachusetts Dana Farber/ Harvard Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York University of Rochester Rochester, New York, United States, 14642 United States, South Carolina Greenville Hospital System Greenville, South Carolina, United States, 29605 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75230 Less <<
NCT02590588	Amyloidosis	PHASE2	TERMINATED	2017-03-27	Boston Medical Center, Boston,... More >> Massachusetts, 02118, United States Less <<
NCT01203930	-		Terminated	-	-
NCT01282424	Follicular Lymphoma\|Small Lymp... More >>hocytic Lymphoma\|Lymphoplasmacytic Lymphoma\|Marginal Zone Lymphoma Less <<	PHASE2	COMPLETED	2018-05-16	St. Jude Medical Center, Fulle... More >>rton, California, 92835, United States\|Pacific Shores Medical Group, Long Beach, California, 90813-3244, United States\|UCLA, Los Angeles, California, 90095, United States\|Central Coast Medical Oncology, Santa Maria, California, 93454, United States\|Stanford Cancer Center, Stanford, California, 94035-5796, United States\|Collaborative Research Group, LLC, Boynton Beach, Florida, 33435, United States\|Winship Cancer Institute, Atlanta, Georgia, 30322-1013, United States\|Northwestern University Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, 60611, United States\|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States\|John Theurer Cancer Center Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States\|University of Medicine and Dentistry of NJ, New Brunswick, New Jersey, 08901-1914, United States\|Weill Cornell -New York Presbyterian Hospital, New York, New York, 10002, United States\|Montefiore Medical Center, New York, New York, 10467, United States\|The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States\|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States\|South Carolina Oncology Associates, Columbia, South Carolina, 29210, United States\|Chattanooga Hem/Oncology Ass (SCRI), Chattanooga, Tennessee, 37404, United States\|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States\|Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States\|University of Virginia Medical Center, Charlottesville, Virginia, 22908, United States\|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States\|University of Wisconsin, Madison, Wisconsin, 53792-5156, United States\|CHU Morvan, Brest, 29609, France\|Centre Hospitalier de Lyon Sud, Pierre Benite, 69310, France\|Centre Henri Bequerel, Rouen, 76038, France\|CHU Bretonneau - Centre Kaplan, Tours, 37044, France\|Charité Campus Virchow Klinikum, Berlin, 13353, Germany\|Universit?tsklinikum Essen, Essen, 45147, Germany\|Klinikum der Universit?t München-Gro?hadern, München, 81377, Germany\|Universitatsklinikum Ulm, Ulm, 89081, Germany\|Azienda Ospedaliera di Bologna - Policlinico S. Orsola Malpighi, Bologna, 40138, Italy\|A.O.U. San Martino, Genova, 16132, Italy\|Fondazione Centro San Raffaele del Monte Tabor, Milano, 20132, Italy\|Università "Sapienza", Rome, 00161, Italy\|Ma?opolskie Centrum Medyczne, Kraków, 30-510, Poland\|Centrum Onkologii w Warszawie, Warsaw, 02-781, Poland\|St James's Institute of Oncology, Leeds, LS9 7TF, United Kingdom\|St Bartholemews Hospital, London, EC1M 6BQ, United Kingdom\|Sarah Cannon Institute, London, W1G 6AD, United Kingdom\|The Christie Hospital, Manchester, M20 4BX, United Kingdom\|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom Less <<
NCT01282424	Follicular Lymphoma\|Small Lymp... More >>hocytic Lymphoma\|Lymphoplasmacytic Lymphoma\|Marginal Zone Lymphoma Less <<	PHASE2	COMPLETED	2018-05-16	St. Jude Medical Center, Fulle... More >>rton, California, 92835, United States\|Pacific Shores Medical Group, Long Beach, California, 90813-3244, United States\|UCLA, Los Angeles, California, 90095, United States\|Central Coast Medical Oncology, Santa Maria, California, 93454, United States\|Stanford Cancer Center, Stanford, California, 94035-5796, United States\|Collaborative Research Group, LLC, Boynton Beach, Florida, 33435, United States\|Winship Cancer Institute, Atlanta, Georgia, 30322-1013, United States\|Northwestern University Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, 60611, United States\|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States\|John Theurer Cancer Center Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States\|University of Medicine and Dentistry of NJ, New Brunswick, New Jersey, 08901-1914, United States\|Weill Cornell -New York Presbyterian Hospital, New York, New York, 10002, United States\|Montefiore Medical Center, New York, New York, 10467, United States\|The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States\|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States\|South Carolina Oncology Associates, Columbia, South Carolina, 29210, United States\|Chattanooga Hem/Oncology Ass (SCRI), Chattanooga, Tennessee, 37404, United States\|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States\|Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States\|University of Virginia Medical Center, Charlottesville, Virginia, 22908, United States\|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States\|University of Wisconsin, Madison, Wisconsin, 53792-5156, United States\|CHU Morvan, Brest, 29609, France\|Centre Hospitalier de Lyon Sud, Pierre Benite, 69310, France\|Centre Henri Bequerel, Rouen, 76038, France\|CHU Bretonneau - Centre Kaplan, Tours, 37044, France\|Charité Campus Virchow Klinikum, Berlin, 13353, Germany\|Universit?tsklinikum Essen, Essen, 45147, Germany\|Klinikum der Universit?t München-Gro?hadern, München, 81377, Germany\|Universitatsklinikum Ulm, Ulm, 89081, Germany\|Azienda Ospedaliera di Bologna - Policlinico S. Orsola Malpighi, Bologna, 40138, Italy\|A.O.U. San Martino, Genova, 16132, Italy\|Fondazione Centro San Raffaele del Monte Tabor, Milano, 20132, Italy\|Università "Sapienza", Rome, 00161, Italy\|Ma?opolskie Centrum Medyczne, Kraków, 30-510, Poland\|Centrum Onkologii w Warszawie, Warsaw, 02-781, Poland\|St James's Institute of Oncology, Leeds, LS9 7TF, United Kingdom\|St Bartholemews Hospital, London, EC1M 6BQ, United Kingdom\|Sarah Cannon Institute, London, W1G 6AD, United Kingdom\|The Christie Hospital, Manchester, M20 4BX, United Kingdom\|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom Less <<
NCT01659021	Chronic Lymphocytic Leukemia	Phase 3	Completed	-	-
NCT02439138	Waldenstrom's Macroglobulinemi... More >>a Less <<	PHASE2	TERMINATED	2025-04-16	Dana Farber Cancer Institute, ... More >>Boston, Massachusetts, 02215, United States Less <<
NCT03639324	Chronic Lymphocytic Leukemia ... More >> CLL Relapsed CLL Refractory Chronic Lymphocytic Leukemia Relapsed Chronic Lymphocytic Leukemia Less <<	Phase 1	Not yet recruiting	September 30, 2025	United States, Virginia ... More >> Virginia Commonwealth University/ Massey Cancer Center Not yet recruiting Richmond, Virginia, United States, 23298 Contact: Yazbeck Y Victor, MD, MS 804-628-2073 victor.yazbeck@vcuhealth.org Contact: Caryn R Weir, RN, M.P.H. 804-628-2310 cweir@vcu.edu Less <<
NCT02590588	Amyloidosis	PHASE2	TERMINATED	2017-03-27	Boston Medical Center, Boston,... More >> Massachusetts, 02118, United States Less <<
NCT03568929	Follicular Non-Hodgkin's Lymph... More >>oma Refractory Less <<		COMPLETED	2021-10-29	Ziekenhuis Netwerk Antwerpen S... More >>tuivenberg Hospital, Antwerpen, 2060, Belgium\|Centre Hospitalier Universitaire d'Amiens (CHU d'Amiens) - Hopital Nord, Amiens Cedex 1, 80054, France\|Centre Hospitalier Bourg-en-Bresse Fleyriat, Bourg-en-Bresse, France\|Centre Hospitalier de Cannes, Cannes, 06400, France\|H?pital Privé Sévigné, Cesson-Sevigne, France\|Centre Hospitalier Chalon sur Sa?ne William Morey, Chalon-Sur-Saone, 71100, France\|Centre Hospitalier Universitaire Estaing, Clermont-Ferrand, 63003, France\|CHU de Dijon, Dijon, 2100, France\|Groupe Hospitalier Mutualiste de Grenoble - Institut Daniel Hollard, Grenoble, France\|Clinique Victor Hugo, Le Mans Cedex 2, 72015, France\|Centre Hospitalier Le Mans, Le Mans, 72037, France\|Centre Hospitalier de Lens, Lens, 62300, France\|H?pital de la Conception, Marseille, 13005, France\|Centre Hospitalier Régional d'Orléans, Orléans, 45650, France\|Centre hospitalier de Perigueux, Pessac, 33604, France\|Centre Hospitalier Lyon Sud, Pierre Bénite Cedex, 69495, France\|Centre Hospitalier Universitaire de Poitiers, Poitiers Cedex, 86021, France\|Hopital Bretonneau, Centre Henri Kaplan, Tours, Cedex 37044, France\|Klinikum Frankfurt Hochst, Frankfurt, 65929, Germany\|Universit?tsmedizin G?ttingen, G?ttingen, 37075, Germany\|Klinikum Südstadt Rostock, Rostock, Germany\|Gemeinschaftspraxis für H?matologie und Onkologie Westerstede, Westerstede, 26655, Germany\|University General Hospital of Alexandroupolis, Alexandroupolis, 68100, Greece\|Athens Medical Center-Psychikon branch, Athens, 11525, Greece\|Henry Dunant Hospital, Athens, 11526, Greece\|University General Hospital of Patras, Patra, 265 04, Greece\|AHEPA University General Hospital of Thessaloniki, Thessaloniki, 54636, Greece\|Saint James's Hospital, Dublin, 8, Ireland\|Mater Misericordiae University Hospital, Dublin, Dublin 7, Ireland\|Midland Regional Hospital - Mullingar, Mullingar, Ireland\|Ospedali Riuniti di Ancona, Clinica Ematologica, Ancona, 60126, Italy\|Ospedale Mazzoni, Ascoli Piceno, Italy\|Azienda Ospedaliera Policlinico di Bari, Bari, 70124, Italy\|Monsignor Raffaele Dimiccoli Hospital, Barletta, 70051, Italy\|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia, 25123, Italy\|Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi, Catania, 95122, Italy\|Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele, Catania, 95124, Italy\|Ospedale di Civitanova Marche, Civitanova Marche, Italy\|Azienda Ospedaliero - Universitaria Careggi, Florence, 50134, Italy\|Presidio Ospedaliero di Livorno, Livorno, Italy\|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, 47014, Italy\|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, 20100, Italy\|Fondazione IRCCS Cà Grande Ospedale Maggiore Policlinico, Milano, 20122, Italy\|Istituto Scientifico Universitario San Raffaele, Milano, 20132, Italy\|Azienda Ospedaliera Universitaria Maggiore Della Carita di Novara, Novara, 28100, Italy\|Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy\|Azienda Ospedaliera di Perugia, Perugia, 06129, Italy\|Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, 61122, Italy\|Azienda Unità Sanitaria Locale di Piacenza-Ospedale Guglielmo da Saliceto, Piacenza, Italy\|Azienda Unita Sanitaria Locale di Ravenna, Ravenna, 48121, Italy\|Arcispedale Santa Maria Nuova, Reggio Emilia, 42123, Italy\|IRCCS Centro di Riferimento Oncologico di Basilicata di Rionero in Vulture, Rionero in Vulture, 85028, Italy\|Universita degli Studi di Roma La Sapienza, Roma, 00161, Italy\|Istituti di Ricovero e Cura A Carattere Scientifico - Istituti Fisioterapici Ospitalieri, Roma, Italy\|Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, 71013, Italy\|Azienda Ospedaliera Universitaria Senese-L'ospedale Santa Maria alle Scotte, Siena, 53100, Italy\|Ospedale San Bortolo di Vicenza, Vicenza, Italy\|Instituto Português de Oncologia Francisco Gentil, Centro Regional de Lisboa SA, Lisbon, 1090-023, Portugal\|Fundació Hospital de la Santa Creu i Sant Pau, Barcelona, Catalu?a, 8025, Spain\|Hospital General Universitario de Alicante, Alicante, 3011, Spain\|Hospital Universitari Germans Trias i Pujol, Badalona, 08916, Spain\|Hospital Universitari Mútua Terrassa, Barcelona, 8221, Spain\|Hospital Universitario de Burgos, Burgos, 09006, Spain\|Hospital De Cabuenes, Gijon, 33394, Spain\|Hospital Universitario Donostia, Gipuzkoa, 20014, Spain\|Institut Català d'Oncologia, L'Hospitalet de LLobregat, Spain\|Hospital Universitario Severo Ochoa, Leganés, 28911, Spain\|Hospital General Universitario Gregorio Maranon, Madrid, 28007, Spain\|Hospital San Pedro de Alcantara, Madrid, 28009, Spain\|Hospital Universitario Infanta Leonor, Madrid, 28031, Spain\|Hospital Universitario Ramon Y Cajal, Madrid, 28034, Spain\|Hospital Universitario Fundacion Jimenez Diaz, Madrid, 28040, Spain\|Hospital General Universitario Morales Meseguer, Murcia, 30008, Spain\|Hospital Universitario Virgen de la Arrixaca, Murcia, 30120, Spain\|Hospital Universitario Rey Juan Carlos, Móstoles, Spain\|Hospital Universitario Central de Asturias, Oviedo, 33004, Spain\|Hospital Universitario Son Dureta, Palma de Mallorca, Spain\|Clínica Universidad de Navarra, Pamplona, 31008, Spain\|Hospital Universitario de Salamanca, Salamanca, 37007, Spain\|Hospital Universitario de Canarias, Santa Cruz de Tenerife, 38320, Spain\|Hospital Universitari Arnau De Vilanova (Huav), Valencia, 46015, Spain\|Hospital Clinico Universitario Lozano Blesa, Zaragoza, 50009, Spain\|Hospital de Día Quirónsalud Zaragoza, Zaragoza, 50012, Spain\|Karolinska Universitetssjukhuset, Stockholm, 141 86, Sweden\|Velindre NHS Trust, Cardiff, United Kingdom\|St George's Healthcare NHS Trust, London, SW17 0QT, United Kingdom\|South Tees Hospitals Nhs Foundation Trust, Middlesbrough, TS4 3BW, United Kingdom\|Abertawe Bro Morgannwg University Health Board, Swansea, SA2 8QA, United Kingdom Less <<
NCT02739360	Lymphoid Malignancies	PHASE4	TERMINATED	2017-12-28	Amsterdam, Netherlands
NCT02439138	Waldenstrom's Macroglobulinemi... More >>a Less <<	PHASE2	TERMINATED	2025-04-16	Dana Farber Cancer Institute, ... More >>Boston, Massachusetts, 02215, United States Less <<
NCT01090414	Chronic Lymphocytic Leukemia\|L... More >>ymphoma, Non-Hodgkin Less <<	PHASE1\|PHASE2	TERMINATED	2018-06-18	Clearview Cancer Institute, Hu... More >>ntsville, Alabama, 35805, United States\|UCLA, Los Angeles, California, 90095-1678, United States\|Stanford Cancer Center, Palo Alto, California, 94304-5548, United States\|Center for Cancer & Blood Disorders, PC, Bethesda, Maryland, 20817, United States\|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States\|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States\|Long Island Jewish medical Center, New Hyde Park, New York, 11042, United States\|Memorial Sloan-Kettering Cancer Center, New York, New York, 10021, United States\|Weill Medical College of Cornell, New York, New York, 10021, United States\|Mount Sinai School of Medicine, New York, New York, 10029, United States\|The Ohio State University Medical Center, Columbus, Ohio, 43210, United States\|Oregon Health & Science University, Portland, Oregon, 97239, United States\|Willamette Valley Cancer Institute and Research Center, Springfield, Oregon, 97477, United States\|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States\|MD Anderson Cancer and Research Center, Houston, Texas, 77030, United States\|MD Anderson Cancer Center, Houston, Texas, 77030, United States\|Yakima Regional Cancer Care, Yakima, Washington, 98902, United States\|University of Wisconsin, Madison, Wisconsin, 53792-5156, United States Less <<
NCT02135133	Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less <<	Phase 2	Active, not recruiting	March 2021	United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02536300	Follicular Lymphoma	PHASE3	TERMINATED	2022-09-27	Calvary Norht Adelaide Hosptia... More >>l, Woodville South, South Australia, 5011, Australia\|Royal Victoria Regional Health Centre, Barrie, L4M 6M2, Canada\|Fakultni nemocnice Brno, Interni hematologicka a onkologicka klinika, Brno, 625 00, Czechia\|Fakultni nemocnice Kralovske Vinohrady, Prague 10, 10034, Czechia\|Fakulni newmcince v Motole, Onkologicka klinika 2. LF UK a FN Motol, Praha 5, 150 06, Czechia\|Centre Hospitalier d'Avignon-Hopital Henri Duffaut, Avignon, 84000, France\|Polyclinique Bordeaux Nord Aquitaine, Bordeaux, 33077, France\|Centre Hospitalier Le Mans, Le Mans, 72037, France\|Hopital Saint Louis, Paris Cedex 10, 75475, France\|Hopital Saint Antoine, Paris cedex 12, 72012, France\|Centre Hospitalier Universaitaire de Poit iers-Pole Regional de Cancerlogie, Poitiers Cedex, 86021, France\|Centre Hospitalier de Tours-Hopital Bretoneau Centre Regional de Cancerologie Henry Kaplan, Tours Cedex, 37044, France\|Clinique Louis Pasteur, Vandoeuvre-lés-Nancy, 54511, France\|Carmel Medical Center, Haifa, 34362, Israel\|Meir Medical Center, Kfar Saba, 4428164, Israel\|Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, 24127, Italy\|ASST Spedali Civili, Brescia, 25123, Italy\|Ospedale Policlinico San Martino IRCCS-Clinica Ematologica, Genoa, 16132, Italy\|Azienda Policlinico San Martino, Genova, 16132, Italy\|Azienda Ospedaliera Cardinale G Panico di Tricase-Unita Operativa Complessa di Ematologia e TMO, Lecce, 73039, Italy\|Azienda Ospedaliera Vito Fazzi Unita Operativa di Ematologia, Lecce, 73100, Italy\|Instituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Dipartimento di Oncologia Medica, Meldola, 47014, Italy\|IRCCS Ospendale San Raffaele, Milano, 20132, Italy\|SCDU Ematologia e Terapie Cellulari Azienda Ospedaliera Ordine Mauriziano di Torino, Orbassano, 10043, Italy\|Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, 90146, Italy\|Azienda Unita Sanitaria Locale di Ravenna, U.O di Ematologia, Ravenna, 48121, Italy\|Ospedale degli Infermi-Oncoematologia, Rimini, 47900, Italy\|Fondazione Policlinico Tor Vergata-UOC Patologie Linfoproliferative, Rome, 00133, Italy\|Ospedale S. Eugenio, Rome, 00144, Italy\|Dipartimento di Ematologia ed Oncoematolgia - S.C Ematolgia, Torino, 10126, Italy\|A.S.U. Integrata Santa Maria della Misericordia, Udine, 33100, Italy\|Szpitale Wojewodzkie w Gdyni Sp. z o.o., Gdynia, 81-519, Poland\|PRATIA Onkologia Katowice, Katowice, 40-519, Poland\|Malopolskie Centrum Medyczne, Kraków, 30-510, Poland\|Wojewodzki Szpital Specjalistyczny w Legniicy, Legnica, 59-220, Poland\|Gabinety Lekarskie Hema, Lublin, 20-090, Poland\|Szpital Wojewodzki w Opolu Sp. z o.o., Opole, 45-372, Poland\|Instytut Hematologii i Transfuzjologii, Klinika Hematologii, Warszawa, 02-776, Poland\|Centrum Onkologii Instytut im.Marii Sklodowskiej Curie, Warszawa, 02-781, Poland\|Klinika Hematologii Nowotworow Kriwi i Transplantacji Szpiku, Wroclaw, 50-367, Poland\|Spitalul Judetean de Urgenta "Dr. Constantin Opris" Baia Mare, Baia Mare, 430031, Romania\|Hospital del Mar, Barcelona, 08003, Spain\|Hospital Universitario de Burgos, Burgos, 09006, Spain\|Hospital San Pedro de Alcantara, Cáceres, 10003, Spain\|Institut Catala d'Oncologia Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, 08908, Spain\|Hospital General Universiario Gregorio Maranon, Madrid, 28009, Spain\|Hospital Universitario Infanta Leonor, Madrid, 28031, Spain\|Hospital Universitario Ramon y Cajal, Madrid, 28034, Spain\|Fundacion Jimenez Diaz, Madrid, 28040, Spain\|Centro Integral Oncologico Clara Campal (CIOCC), Madrid, 28050, Spain\|Hospital Puerta de Hierro Majadahonda, Majadahonda, 28222, Spain\|Hospital Genereal Universitario Morales Meseguer, Murcia, 30008, Spain\|Hospital Son Llatzer, Palma de Mallorca, 07198, Spain\|Hospital Universitario de Canarias, Santa Cruz de Tenerife, 38320, Spain\|Hospital Universitario Marques de Valdecilla, Santander, 39008, Spain\|Hospital Universitario Mutua Terrassa, Terrassa, 08221, Spain\|CEIm-Regional De La Comunidad De Madrid, Valencia, 46026, Spain\|Hospital Clinico Universitario Lozano Blesa, Zaragoza, 50009, Spain\|East Kent Hospitals University NHS Foundation Trust, Canterbury, CT1 3NG, United Kingdom\|London North West University Healthcare NHS Trust, Harrow, HA1 3UJ, United Kingdom\|Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, L7 8XP, United Kingdom\|Barts Health Trust, London, EC1A7BE, United Kingdom\|University College London Hospitals NHS Foundation Trust, London, NW1 2PG, United Kingdom\|St George's Hospital NHS Trust, London, SW17 0QT, United Kingdom\|The Pennine Acute Hospital NHS Trust, Oldham, OL1 2JH, United Kingdom\|Torbay and South Devon NHS Foundation Trust, Torquay, TQ2 7AA, United Kingdom Less <<
NCT03742323	Acute Lymphoblastic Leukemia	PHASE1\|PHASE2	TERMINATED	2020-06-02	Hospital ICO Badalona, Badalon... More >>a, Spain\|Hospital Clinic de Barcelona, Barcelona, Spain\|Hospital Vall d'Hebrón, Barcelona, Spain\|Hospital ICO Hospitalet, Hospitalet de Llobregat, Spain\|Hospital 12 de Octubre, Madrid, Spain\|H. Morales Meseguer, Murcia, Spain\|H. Virgen de la Victoria, Málaga, Spain\|Hospital Clinico de Salamanca, Salamanca, Spain\|Hospital Marques de Valdecilla, Santander, Spain\|H. Universitario Virgen de Rocío, Sevilla, Spain\|Hospital Clínico Valencia, Valencia, Spain\|Hospital Universitario y Politécnico la Fe, Valencia, Spain Less <<
NCT02436135	Myelofibrosis	Phase 1	Completed	-	United States, California ... More >> Stanford Hospital and Clinics Stanford, California, United States, 94305 United States, Michigan University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Less <<
NCT01659021	-		Completed	-	-
NCT01306643	Indolent Non-Hodgkin's Lymphom... More >>a\|Follicular Lymphoma\|Small Lymphocytic Lymphoma\|Marginal Zone Lymphoma Less <<	PHASE1\|PHASE2	COMPLETED	2025-08-15	Stanford Cancer Center, Palo A... More >>lto, California, 94304-5548, United States\|Mount Sinai School of Medicine, New York, New York, 10029, United States Less <<
NCT01306643	Indolent Non-Hodgkin's Lymphom... More >>a\|Follicular Lymphoma\|Small Lymphocytic Lymphoma\|Marginal Zone Lymphoma Less <<	PHASE1\|PHASE2	COMPLETED	2025-08-15	Stanford Cancer Center, Palo A... More >>lto, California, 94304-5548, United States\|Mount Sinai School of Medicine, New York, New York, 10029, United States Less <<
NCT03151057	B Cells-Tumors ... More >> B Cell Chronic Lymphocytic Leukemia Follicular Lymphoma Mantle Cell Lymphoma Large B-Cell Diffuse Lymphoma of Bone (Diagnosis) Less <<	Phase 1	Recruiting	December 2020	United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21205 Contact: Douglas Gladstone, MD 410-955-8781 dgladst1@jhmi.edu Contact: Mary A Stevens, MD 443-287-0180 msteve35@jhmi.edu Less <<
NCT03582098	-		Recruiting	December 2018	Ireland ... More >> St James Hospital Recruiting Dublin, Ireland, 8 United Kingdom NHS Grampian Recruiting Aberdeen, United Kingdom, AB25 2ZN University Hospital of Wales Not yet recruiting Cardiff, United Kingdom, CF14 4XW Cheltenham General Hospital Recruiting Cheltenham, United Kingdom, GL53 7AN London Northwest University NHS Trust Recruiting Eastcote, United Kingdom, HA4 8PD Milton Keynes University Hospital Not yet recruiting Milton Keynes, United Kingdom, MK6 5LD Oxford University Hospitals NHS Trust Recruiting Oxford, United Kingdom, OX3 7LE Whiston Hospital - St Helens And Knowsley Teaching Hospitals NHS Trust Recruiting Prescot, United Kingdom, L35 5DR Southend University Hospital NHS Foundation Trust Recruiting Southend-On-Sea, United Kingdom, SS0 0RY Singleton Hospital Not yet recruiting Swansea, United Kingdom, SA2 8QA Royal Cornwall Hospital Recruiting Truro, United Kingdom, TR1 3LJ Worcestershire Royal Hospital Recruiting Worcester, United Kingdom, WR5 1DD Less <<
NCT00710528	Chronic Lymphocytic Leukemia (... More >>CLL)\|Lymphoma, Non-Hodgkin (NHL)\|Acute Myeloid Leukemia (AML)\|Multiple Myeloma (MM) Less <<	PHASE1	COMPLETED	2025-08-12	Stanford Cancer Center, Palo A... More >>lto, California, 94304-5548, United States\|The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, Maryland, 21231, United States\|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States\|Washington University School of Medicine, St. Louis, Missouri, 63110, United States\|Weill Medical College of Cornell, New York, New York, 10021, United States\|The Ohio State University Medical Center, Columbus, Ohio, 43210, United States\|Oregon Health and Science University, Portland, Oregon, 97239-3098, United States\|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States\|University of Wisconsin, Madison, Wisconsin, 53792-5156, United States Less <<
NCT01659047	Chronic Lymphocytic Leukemia	PHASE2	WITHDRAWN	2025-12-15	-
NCT01393106	Hodgkin Lymphoma	PHASE2	COMPLETED	2025-08-14	Memorial Sloan Kettering Cance... More >>r Center, New York, New York, 10065, United States\|MD Anderson Cancer Center, Houston, Texas, 77030, United States\|Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States Less <<
NCT03133221	Non Hodgkin Lymphoma ... More >> Follicular Lymphoma Indolent Lymphoma B-cell Lymphoma Transformed Lymphoma Marginal Zone Lymphoma Waldenstrom Macroglobulinemia Small Lymphocytic Lymphoma Lymphoplasmacytic Lymphoma Less <<	Phase 2	Recruiting	March 2022	United States, Maryland ... More >> Greenebaum Cancer Center at University of Maryland Medical Center Recruiting Baltimore, Maryland, United States, 21201-1592 Contact: Sunita Philip, MPH, CCRP 410-328-8199 sphilip1@umm.edu Contact: Carolynn G. Harris, BA, CCRP 410-328-8198 charris@umm.edu United States, Missouri Washington University School of Medicine Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: Amanda Cashen, MD 314-454-8306 acashen@DOM.wustl.edu United States, Virginia Virginia Commonwealth University Not yet recruiting Richmond, Virginia, United States, 23298 Contact: Victor Yazbeck, MD 804-628-2073 vyyazbeck@vcu.edu Less <<
NCT01393106	Hodgkin Lymphoma	PHASE2	COMPLETED	2025-08-14	Memorial Sloan Kettering Cance... More >>r Center, New York, New York, 10065, United States\|MD Anderson Cancer Center, Houston, Texas, 77030, United States\|Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States Less <<
NCT02445131	Chronic Lymphocytic Leucemia	Phase 2	Recruiting	May 2020	Germany ... More >> German CLL Study Group Recruiting Cologne, Germany, 50935 Contact: Paula Cramer, Dr. med. 0221 478 88220 paula.cramer@uk-koeln.de Contact: Julia von Tresckow, Dr. med. 0221 478 88220 julia.von-tresckow@uk-koeln.de Less <<
NCT02242045	Chronic Lymphocytic Leukemia\|I... More >>ndolent Non-Hodgkin Lymphoma\|Follicular Lymphoma\|Small Lymphocytic Lymphoma\|Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)\|Marginal Zone Lymphoma Less <<	PHASE1	COMPLETED	2017-10-17	Aichi, Japan\|Miyagi, Japan\|Tok... More >>yo, Japan Less <<
NCT00836914	Allergic Rhinitis	Phase 1	Completed	-	Austria ... More >> Vienna Challenge Chamber Vienna, Austria Less <<

CAS No. :	870281-82-6
Formula :	C₂₂H₁₈FN₇O
M.W :	415.42
SMILES Code :	O=C1N(C2=CC=CC=C2)C([C@@H](NC3=C4N=CNC4=NC=N3)CC)=NC5=C1C(F)=CC=C5
Synonyms :	CAL-101; GS-1101; GS-1101, Idelalisib.
MDL No. :	MFCD19443647
InChI Key :	IFSDAJWBUCMOAH-HNNXBMFYSA-N
Pubchem ID :	11625818

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

murine thymocytes	10 µM	not mentioned	To investigate the effect of Idelalisib on thymocyte respiration, results showed that Idelalisib had no significant effect on thymocyte respiration	PMC4966723
HCT-116 cells	10 μM	48 h	Inhibition of PIK3CD significantly suppressed the growth, migration, and invasion of HCT-116 cells.	PMC6398891
Huh-BAT	20 μM	48 h	Suppressed HCC cell proliferation and induced cell cycle arrest, reduced cell invasion, upregulated E-cadherin expression, and downregulated N-cadherin and Snail expression.	PMC7641573
HepG2	20 μM	48 h	Suppressed HCC cell proliferation and induced cell cycle arrest, reduced cell invasion, upregulated E-cadherin expression, and downregulated N-cadherin and Snail expression.	PMC7641573
MEC1 cells	2 μM	5 days	To investigate the effect of Idelalisib on Rictor and pAktS473 levels in MEC1 cells, results showed upregulation of Rictor and pAktS473 levels.	PMC11601945
CLL cells	1 μM	48 h	To investigate the effect of Idelalisib on Akt phosphorylation in CLL cells, results showed inhibition of Akt phosphorylation.	PMC11601945
Human platelets	10 µM	10 min	To evaluate the inhibitory effect of PI3K inhibitors on intracellular calcium release induced by the GPVI-specific agonist CRP, results showed that Idelalisib significantly inhibited calcium release.	PMC8037016
Human platelets	10 µM	10 min	To assess the potential toxicity of Idelalisib on platelet viability using Calcein-AM flow cytometry, results showed that platelets remained highly viable after Idelalisib treatment.	PMC8037016
SUM159	25 μM	96 h	To test the growth inhibitory effect of Idelalisib on TNBC cells	PMC6359814
BT549	25 μM	96 h	To test the growth inhibitory effect of Idelalisib on TNBC cells	PMC6359814

mice	C57BL/6 mice	intraperitoneal injection	2.5 µg/g	once daily for 4 days	To investigate the effect of Idelalisib on thymus size, results showed that Idelalisib had no significant effect on thymus size	PMC4966723
nude mice	HCT-116 xenograft model	oral	30 mg/kg/d	once daily for 10 days	Inhibition of PIK3CD significantly suppressed the growth of HCT-116 xenograft tumors.	PMC6398891
Mice	ITK-SYKCD4-CreERT2;PD-1-/- mice	Oral	10 mg/kg	5 days a week for 5 days	To study the effect of PI3K inhibition on ITK-SYK+PD-1-/- lymphoma mice, results showed that PI3K inhibition significantly extended the lifespan of these mice.	PMC5821214
Mice	FeCl3-induced arterial thrombosis model	Oral administration	20 mg/kg	Single dose, experiments performed 1 hour after administration	To evaluate the antithrombotic effect of Idelalisib in the FeCl3-induced arterial thrombosis model, results showed that Idelalisib significantly prolonged the occlusion time, indicating its antithrombotic potential.	PMC8037016
Nude mice	HCT 116 xenograft model	Intragastric administration	15 mg/kg	Once daily for 21 days	To evaluate the antitumor effect of Idelalisib in vivo on KRAS-mutant colorectal cancer, the results showed that Idelalisib significantly inhibited tumor growth without obvious hepatotoxicity or renal toxicity.	PMC11220027

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.41mL 0.48mL 0.24mL	12.04mL 2.41mL 1.20mL	24.07mL 4.81mL 2.41mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

{[proInfo.proName]}

CAS No.: 870281-82-6

{[proInfo.proName]}

CAS No.: 870281-82-6

Alternative Products

Product Details of Idelalisib

Safety of Idelalisib

Related Pathways of Idelalisib

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed